Malmstrom V, Catrina AI and Klareskog L: The immunopathogenesis of seropositive rheumatoid arthritis: From triggering to targeting. Nat Rev Immunol. 17:60–75. 2017. View Article : Google Scholar : PubMed/NCBI

Weyand CM and Goronzy JJ: The immunology of rheumatoid arthritis. Nat Immunol. 22:10–18. 2021. View Article : Google Scholar : PubMed/NCBI

Scherer HU, Haupl T and Burmester GR: The etiology of rheumatoid arthritis. J Autoimmun. 110:1024002020. View Article : Google Scholar : PubMed/NCBI

Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J and Zhang L: B Cells in Rheumatoid Arthritis: Pathogenic mechanisms and treatment prospects. Front Immunol. 12:7507532021. View Article : Google Scholar : PubMed/NCBI

Safiri S, Kolahi AA, Hoy D, Smith E, Bettampadi D, Mansournia MA, Almasi-Hashiani A, Ashrafi-Asgarabad A, Moradi-Lakeh M, Qorbani M, et al: Global, regional and national burden of rheumatoid arthritis 1990–2017: A systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis. 78:1463–1471. 2019. View Article : Google Scholar : PubMed/NCBI

Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cárdenas-de la Garza JA, Vera-Pineda R, Wah-Suárez M, Arvizu-Rivera RI, Martínez-Moreno A, Ramos-Cázares RE, Torres-Quintanilla FJ, et al: Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis. Rheumatol Int. 37:1507–1511. 2017. View Article : Google Scholar : PubMed/NCBI

Cardiel MH, Pons-Estel BA, Sacnun MP, Wojdyla D, Saurit V, Marcos JC, Pinto MR, Cordeiro de Azevedo AB, da Silveira IG, Radominski SC, et al: Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: The GLADAR experience. J Clin Rheumatol. 18:327–335. 2012. View Article : Google Scholar : PubMed/NCBI

Castillo-Canon JC, Trujillo-Caceres SJ, Bautista-Molano W, Valbuena-García AM, Fernández-Ávila DG and Acuña-Merchán L: Rheumatoid arthritis in Colombia: A clinical profile and prevalence from a national registry. Clin Rheumatol. 40:3565–3573. 2021. View Article : Google Scholar : PubMed/NCBI

D'elia HF, Larsen A, Mattsson LA, Waltbrand E, Kvist G, Mellström D, Saxne T, Ohlsson C, Nordborg E and Carlsten H: Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. J Rheumatol. 30:1456–1463. 2003.PubMed/NCBI

Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA. 288:321–333. 2002. View Article : Google Scholar : PubMed/NCBI

Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, et al: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA. 291:1701–1712. 2004. View Article : Google Scholar : PubMed/NCBI

Daraghmeh DN, Hopkins AM, King C, Abuhelwa AY, Wechalekar MD, Proudman SM, Sorich MJ and Wiese MD: Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs. Rheumatology (Oxford). 62:583–595. 2023. View Article : Google Scholar : PubMed/NCBI

Gomez-Puerta JA, Celis R, Hernandez MV, Ruiz-Esquide V, Ramírez J, Haro I, Cañete JD and Sanmartí R: Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and -negative rheumatoid arthritis patients. Arthritis Res Ther. 15:R1822013. View Article : Google Scholar : PubMed/NCBI

Van Den Broek M, Dirven L, Klarenbeek NB, Molenaar TH, Han KH, Kerstens PJ, Huizinga TW, Dijkmans BA and Allaart CF: The association of treatment response and joint damage with ACPA-status in recent-onset RA: A subanalysis of the 8-year follow-up of the BeSt study. Ann Rheum Dis. 71:245–248. 2012. View Article : Google Scholar : PubMed/NCBI

Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, Klareskog L and Dahlqvist SR: A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther. 6:R303–R308. 2004. View Article : Google Scholar : PubMed/NCBI

Johansson M, Arlestig L, Hallmans G and Rantapää-Dahlqvist S: PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res Ther. 8:R192006. View Article : Google Scholar : PubMed/NCBI

Ge C and Holmdahl R: The structure, specificity and function of anti-citrullinated protein antibodies. Nat Rev Rheumatol. 15:503–508. 2019. View Article : Google Scholar : PubMed/NCBI

Kissel T, Reijm S, Slot LM, Cavallari M, Wortel CM, Vergroesen RD, Stoeken-Rijsbergen G, Kwekkeboom JC, Kampstra A, Levarht E, et al: Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications. Ann Rheum Dis. 79:472–480. 2020. View Article : Google Scholar : PubMed/NCBI

Shlomchik MJ, Craft JE and Mamula MJ: From T to B and back again: Positive feedback in systemic autoimmune disease. Nat Rev Immunol. 1:147–153. 2001. View Article : Google Scholar : PubMed/NCBI

Yan J, Harvey BP, Gee RJ, Shlomchik MJ and Mamula MJ: B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J Immunol. 177:4481–4487. 2006. View Article : Google Scholar : PubMed/NCBI

Weyand CM and Goronzy JJ: Immunometabolism in early and late stages of rheumatoid arthritis. Nat Rev Rheumatol. 13:291–301. 2017. View Article : Google Scholar : PubMed/NCBI

Weyand CM, Shen Y and Goronzy JJ: Redox-sensitive signaling in inflammatory T cells and in autoimmune disease. Free Radic Biol Med. 125:36–43. 2018. View Article : Google Scholar : PubMed/NCBI

Wu B, Goronzy JJ and Weyand CM: Metabolic fitness of t cells in autoimmune disease. Immunometabolism. 2:e2000172020. View Article : Google Scholar : PubMed/NCBI

Ponchel F, Burska AN, Hunt L, Gul H, Rabin T, Parmar R, Buch MH, Conaghan PG and Emery P: T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: Implications for management. Sci Rep. 10:36692020. View Article : Google Scholar : PubMed/NCBI

Paunovic V, Carroll HP, Vandenbroeck K and Gadina M: Signalling, inflammation and arthritis: crossed signals: The role of interleukin (IL)-12, −17, −23 and −27 in autoimmunity. Rheumatology (Oxford). 47:771–776. 2008. View Article : Google Scholar : PubMed/NCBI

Kim W, Min S, Cho M, Youn J, Min J, Lee S, Park S, Cho C and Kim H: The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA). Clin Exp Immunol. 119:175–181. 2000. View Article : Google Scholar : PubMed/NCBI

Chu CQ, Swart D, Alcorn D, Tocker J and Elkon KB: Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum. 56:1145–1151. 2007. View Article : Google Scholar : PubMed/NCBI

Geboes L, De Klerck B, Van Balen M, Kelchtermans H, Mitera T, Boon L, De Wolf-Peeters C and Matthys P: Freund's complete adjuvant induces arthritis in mice lacking a functional interferon-gamma receptor by triggering tumor necrosis factor alpha-driven osteoclastogenesis. Arthritis Rheum. 56:2595–2607. 2007. View Article : Google Scholar : PubMed/NCBI

Sigidin YA, Loukina GV, Skurkovich B and Skurkovich S: Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis. Scand J Rheumatol. 30:203–207. 2001. View Article : Google Scholar : PubMed/NCBI

Ortmann RA and Shevach EM: Susceptibility to collagen-induced arthritis: Cytokine-mediated regulation. Clin Immunol. 98:109–118. 2001. View Article : Google Scholar : PubMed/NCBI

Haikal SM, Abdeltawab NF, Rashed LA, Abd El-Galil TI, Elmalt HA and Amin MA: Combination Therapy of Mesenchymal Stromal Cells and Interleukin-4 Attenuates Rheumatoid Arthritis in a Collagen-Induced Murine Model. Cells. 8:8232019. View Article : Google Scholar : PubMed/NCBI

Steinman L: A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 13:139–145. 2007. View Article : Google Scholar : PubMed/NCBI

Krebs CF and Steinmetz OM: CD4(+) T Cell Fate in Glomerulonephritis: A Tale of Th1, Th17, and Novel Treg Subtypes. Mediators Inflamm. 2016:53938942016. View Article : Google Scholar : PubMed/NCBI

Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, Gattorno M, Monticelli S, Lanzavecchia A and Sallusto F: Pathogen-induced human TH17 cells produce IFN-ү or IL-10 and are regulated by IL-1β. Nature. 484:514–518. 2012. View Article : Google Scholar : PubMed/NCBI

Evans HG, Roostalu U, Walter GJ, Gullick NJ, Frederiksen KS, Roberts CA, Sumner J, Baeten DL, Gerwien JG, Cope AP, et al: TNF-α blockade induces IL-10 expression in human CD4+ T cells. Nat Commun. 5:31992014. View Article : Google Scholar : PubMed/NCBI

Penatti A, Facciotti F, De Matteis R, Larghi P, Paroni M, Murgo A, De Lucia O, Pagani M, Pierannunzii L, Truzzi M, et al: Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis. Arthritis Res Ther. 19:1032017. View Article : Google Scholar : PubMed/NCBI

Van Hamburg JP, Asmawidjaja PS, Davelaar N, Mus AM, Colin EM, Hazes JM, Dolhain RJ and Lubberts E: Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum. 63:73–83. 2011. View Article : Google Scholar : PubMed/NCBI

Nakae S, Nambu A, Sudo K and Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 171:6173–6177. 2003. View Article : Google Scholar : PubMed/NCBI

Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA and van den Berg WB: Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50:650–659. 2004. View Article : Google Scholar : PubMed/NCBI

Corneth OB, Reijmers RM, Mus AM, Asmawidjaja PS, van Hamburg JP, Papazian N, Siegers JY, Mourcin F, Amin R, Tarte K, et al: Loss of IL-22 inhibits autoantibody formation in collagen-induced arthritis in mice. Eur J Immunol. 46:1404–1414. 2016. View Article : Google Scholar : PubMed/NCBI

Kikuta J, Wada Y, Kowada T, Wang Z, Sun-Wada GH, Nishiyama I, Mizukami S, Maiya N, Yasuda H, Kumanogoh A, et al: Dynamic visualization of RANKL and Th17-mediated osteoclast function. J Clin Invest. 123:866–873. 2013.PubMed/NCBI

Tlustochowicz W, Rahman P, Seriolo B, Krammer G, Porter B, Widmer A and Richards HB: Efficacy and safety of subcutaneous and intravenous loading dose regimens of secukinumab in patients with active rheumatoid arthritis: Results from a randomized phase II study. J Rheumatol. 43:495–503. 2016. View Article : Google Scholar : PubMed/NCBI

Corthay A: How do regulatory T cells work? Scand J Immunol. 70:326–36. 2009. View Article : Google Scholar : PubMed/NCBI

Rudensky AY: Regulatory T cells and Foxp3. Immunol Rev. 241:260–268. 2011. View Article : Google Scholar : PubMed/NCBI

Zhang R, Miao J, Zhang K, Zhang B, Luo X, Sun H, Zheng Z and Zhu P: Th1-like treg cells are increased but deficient in function in rheumatoid arthritis. Front Immunol. 13:8637532022. View Article : Google Scholar : PubMed/NCBI

Nie H, Zheng Y, Li R, Guo TB, He D, Fang L, Liu X, Xiao L, Chen X, Wan B, et al: Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat Med. 19:322–328. 2013. View Article : Google Scholar : PubMed/NCBI

Walter GJ, Fleskens V, Frederiksen KS, Rajasekhar M, Menon B, Gerwien JG, Evans HG and Taams LS: Phenotypic, functional, and gene expression profiling of peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg cells in patients with chronic rheumatoid arthritis. Arthritis Rheumatol. 68:103–116. 2016. View Article : Google Scholar : PubMed/NCBI

Kommoju V, Mariaselvam CM, Bulusu SN, Ganapathy CK, Narasimhan PB, Thabah MM and Negi VS: Conventional Tregs in treatment-naive rheumatoid arthritis are deficient in suppressive function with an increase in percentage of CXCR3 and CCR6 expressing Tregs. Immunol Res. 72:396–408. 2024. View Article : Google Scholar : PubMed/NCBI

Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, Tanaka S, Bluestone JA and Takayanagi H: Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med. 20:62–68. 2014. View Article : Google Scholar : PubMed/NCBI

Gonzalez-Rey E, Gonzalez MA, Varela N, O'Valle F, Hernandez-Cortes P, Rico L, Büscher D and Delgado M: Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis. 69:241–248. 2010. View Article : Google Scholar : PubMed/NCBI

Pedrosa M, Gomes J, Laranjeira P, Duarte C, Pedreiro S, Antunes B, Ribeiro T, Santos F, Martinho A, Fardilha M, et al: Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients. J Tissue Eng Regen Med. 14:16–28. 2020. View Article : Google Scholar : PubMed/NCBI

Ji LS, Sun XH, Zhang X, Zhou ZH, Yu Z, Zhu XJ, Huang LY, Fang M, Gao YT, Li M and Gao YQ: Mechanism of follicular helper T cell differentiation regulated by transcription factors. J Immunol Res. 2020:18265872020. View Article : Google Scholar : PubMed/NCBI

Liu R, Li X, Zhang Z, Zhou M, Sun Y, Su D, Feng X, Gao X, Shi S, Chen W and Sun L: Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis. Sci Rep. 5:127772015. View Article : Google Scholar : PubMed/NCBI

Ma J, Zhu C, Ma B, Tian J, Baidoo SE, Mao C, Wu W, Chen J, Tong J, Yang M, et al: Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol. 2012:8274802012. View Article : Google Scholar : PubMed/NCBI

Wang J, Shan Y, Jiang Z, Feng J, Li C, Ma L and Jiang Y: High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin Exp Immunol. 174:212–220. 2013. View Article : Google Scholar : PubMed/NCBI

Kwok SK, Cho ML, Park MK, Oh HJ, Park JS, Her YM, Lee SY, Youn J, Ju JH, Park KS, et al: Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Arthritis Rheum. 64:740–751. 2012. View Article : Google Scholar : PubMed/NCBI

Jang E, Cho SH, Park H, Paik DJ, Kim JM and Youn J: A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25-T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice. J Immunol. 182:4649–4656. 2009. View Article : Google Scholar : PubMed/NCBI

Olsen NJ, Watson MB, Henderson GS and Kovacs WJ: Androgen deprivation induces phenotypic and functional changes in the thymus of adult male mice. Endocrinology. 129:2471–2476. 1991. View Article : Google Scholar : PubMed/NCBI

Xu D, Wu Y, Gao C, Qin Y, Zhao X, Liang Z, Wang Y, Feng M, Zhang C, Liu G and Luo J: Characteristics of and reference ranges for peripheral blood lymphocytes and CD4+ T cell subsets in healthy adults in Shanxi Province, North China. J Int Med Res. 48:3000605209131492020. View Article : Google Scholar : PubMed/NCBI

Wilkinson NM, Chen HC, Lechner MG and Su MA: Sex differences in immunity. Annu Rev Immunol. 40:75–94. 2022. View Article : Google Scholar : PubMed/NCBI

Cutolo M, Sulli A and Straub RH: Estrogen metabolism and autoimmunity. Autoimmun Rev. 11:A460–A464. 2012. View Article : Google Scholar : PubMed/NCBI

Chakraborty B, Byemerwa J, Krebs T, Lim F, Chang CY and McDonnell DP: Estrogen receptor signaling in the immune system. Endocr Rev. 44:117–141. 2023. View Article : Google Scholar : PubMed/NCBI

Bynote KK, Hackenberg JM, Korach KS, Lubahn DB, Lane PH and Gould KA: Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB × NZW)F1 mice. Genes Immun. 9:137–152. 2008. View Article : Google Scholar : PubMed/NCBI

Li J and Mcmurray RW: Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model. Clin Immunol. 123:219–226. 2007. View Article : Google Scholar : PubMed/NCBI

Svenson JL, Eudaly J, Ruiz P, Korach KS and Gilkeson GS: Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin Immunol. 128:259–268. 2008. View Article : Google Scholar : PubMed/NCBI

Maselli A, Conti F, Alessandri C, Colasanti T, Barbati C, Vomero M, Ciarlo L, Patrizio M, Spinelli FR, Ortona E, et al: Low expression of estrogen receptor beta in T lymphocytes and high serum levels of anti-estrogen receptor alpha antibodies impact disease activity in female patients with systemic lupus erythematosus. Biol Sex Differ. 7:32016. View Article : Google Scholar : PubMed/NCBI

Pierdominici M, Maselli A, Varano B, Barbati C, Cesaro P, Spada C, Zullo A, Lorenzetti R, Rosati M, Rainaldi G, et al: Linking estrogen receptor β expression with inflammatory bowel disease activity. Oncotarget. 6:40443–40451. 2015. View Article : Google Scholar : PubMed/NCBI

Kim DH, Park HJ, Park HS, Lee JU, Ko C, Gye MC and Choi JM: Estrogen receptor α in T cells suppresses follicular helper T cell responses and prevents autoimmunity. Exp Mol Med. 51:1–9. 2019. View Article : Google Scholar : PubMed/NCBI

Guo D, Liu X, Zeng C, Cheng L, Song G, Hou X, Zhu L and Zou K: Estrogen receptor β activation ameliorates DSS-induced chronic colitis by inhibiting inflammation and promoting Treg differentiation. Int Immunopharmacol. 77:1059712019. View Article : Google Scholar : PubMed/NCBI

Maret A, Coudert JD, Garidou L, Foucras G, Gourdy P, Krust A, Dupont S, Chambon P, Druet P, Bayard F and Guéry JC: Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol. 33:512–521. 2003. View Article : Google Scholar : PubMed/NCBI

Lambert KC, Curran EM, Judy BM, Milligan GN, Lubahn DB and Estes DM: Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation. J Immunol. 175:5716–5723. 2005. View Article : Google Scholar : PubMed/NCBI

Polanczyk MJ, Hopke C, Huan J, Vandenbark AA and Offner H: Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol. 170:85–92. 2005. View Article : Google Scholar : PubMed/NCBI

Tai P, Wang J, Jin H, Song X, Yan J, Kang Y, Zhao L, An X, Du X, Chen X, et al: Induction of regulatory T cells by physiological level estrogen. J Cell Physiol. 214:456–464. 2008. View Article : Google Scholar : PubMed/NCBI

Haghmorad D, Amini AA, Mahmoudi MB, Rastin M, Hosseini M and Mahmoudi M: Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells. J Neuroimmunol. 277:85–95. 2014. View Article : Google Scholar : PubMed/NCBI

Pfeilschifter J, Koditz R, Pfohl M and Schatz H: Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 23:90–119. 2002. View Article : Google Scholar : PubMed/NCBI

Sinatora RV, Chagas EFB, Mattera FOP, Mellem LJ, Santos AROD, Pereira LP, Aranão ALC, Guiguer EL, Araújo AC, Haber JFDS, et al: Relationship of inflammatory markers and metabolic syndrome in postmenopausal women. Metabolites. 12:732022. View Article : Google Scholar : PubMed/NCBI

Ralston SH, Russell RG and Gowen M: Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res. 5:983–988. 1990. View Article : Google Scholar : PubMed/NCBI

Lucas-Herald AK and Touyz RM: Androgens and androgen receptors as determinants of vascular sex differences across the lifespan. Can J Cardiol. 38:1854–1864. 2022. View Article : Google Scholar : PubMed/NCBI

Kwon H, Schafer JM, Song NJ, Kaneko S, Li A, Xiao T, Ma A, Allen C, Das K, Zhou L, et al: Androgen conspires with the CD8(+) T cell exhaustion program and contributes to sex bias in cancer. Sci Immunol. 7:eabq26302022. View Article : Google Scholar : PubMed/NCBI

Yang C, Jin J, Yang Y, Sun H, Wu L, Shen M, Hong X, Li W, Lu L, Cao D, et al: Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity. Immunity. 55:1268–1283. e92022. View Article : Google Scholar : PubMed/NCBI

Berrih-Aknin S, Panse RL and Dragin N: AIRE: A missing link to explain female susceptibility to autoimmune diseases. Ann N Y Acad Sci. 1412:21–32. 2018. View Article : Google Scholar : PubMed/NCBI

Zhu ML, Bakhru P, Conley B, Nelson JS, Free M, Martin A, Starmer J, Wilson EM and Su MA: Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator. Nat Commun. 7:113502016. View Article : Google Scholar : PubMed/NCBI

Dragin N, Bismuth J, Cizeron-Clairac G, Biferi MG, Berthault C, Serraf A, Nottin R, Klatzmann D, Cumano A, Barkats M, et al: Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases. J Clin Invest. 126:1525–1537. 2016. View Article : Google Scholar : PubMed/NCBI

Afshan G, Afzal N and Qureshi S: CD4+CD25(hi) regulatory T cells in healthy males and females mediate gender difference in the prevalence of autoimmune diseases. Clin Lab. 58:567–571. 2012.PubMed/NCBI

Gandhi VD, Cephus JY, Norlander AE, Chowdhury NU, Zhang J, Ceneviva ZJ, Tannous E, Polosukhin VV, Putz ND, Wickersham N, et al: Androgen receptor signaling promotes Treg suppressive function during allergic airway inflammation. J Clin Invest. 132:e1533972022. View Article : Google Scholar : PubMed/NCBI

Vargas-Villavicencio JA, Larralde C and Morales-Montor J: Gonadectomy and progesterone treatment induce protection in murine cysticercosis. Parasite Immunol. 28:667–674. 2006. View Article : Google Scholar : PubMed/NCBI

Xia T, Ma J and Sun Y and Sun Y: Androgen receptor suppresses inflammatory response of airway epithelial cells in allergic asthma through MAPK1 and MAPK14. Hum Exp Toxicol. 41:96032712211213202022. View Article : Google Scholar : PubMed/NCBI

Kalidhindi RSR, Ambhore NS, Balraj P, Schmidt T, Khan MN and Sathish V: Androgen receptor activation alleviates airway hyperresponsiveness, inflammation, and remodeling in a murine model of asthma. Am J Physiol Lung Cell Mol Physiol. 320:L803–L818. 2021. View Article : Google Scholar : PubMed/NCBI

Kissick HT, Sanda MG, Dunn LK, Pellegrini KL, On ST, Noel JK and Arredouani MS: Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation. Proc Natl Acad Sci USA. 111:9887–9892. 2014. View Article : Google Scholar : PubMed/NCBI

Klein SL, Jedlicka A and Pekosz A: The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 10:338–349. 2010. View Article : Google Scholar : PubMed/NCBI

Hong CY, Park JH, Ahn RS, Im SY, Choi HS, Soh J, Mellon SH and Lee K: Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol Cell Biol. 24:2593–2604. 2004. View Article : Google Scholar : PubMed/NCBI

Druckmann R and Druckmann MA: Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol. 97:389–396. 2005. View Article : Google Scholar : PubMed/NCBI

Scarpin KM, Graham JD, Mote PA and Clarke CL: Progesterone action in human tissues: Regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl Recept Signal. 7:e0092009. View Article : Google Scholar : PubMed/NCBI

Quispe Calla NE, Ghonime MG, Cherpes TL and Vicetti Miguel RD: Medroxyprogesterone acetate impairs human dendritic cell activation and function. Hum Reprod. 30:1169–1177. 2015. View Article : Google Scholar : PubMed/NCBI

Mao G, Wang J, Kang Y, Tai P, Wen J, Zou Q, Li G, Ouyang H, Xia G and Wang B: Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice. Endocrinology. 151:5477–5488. 2010. View Article : Google Scholar : PubMed/NCBI

Hierweger AM, Engler JB, Friese MA, Reichardt HM, Lydon J, DeMayo F, Mittrücker HW and Arck PC: Progesterone modulates the T-cell response via glucocorticoid receptor-dependent pathways. Am J Reprod Immunol. 81:e130842019. View Article : Google Scholar : PubMed/NCBI

Robinson DP and Klein SL: Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 62:263–271. 2012. View Article : Google Scholar : PubMed/NCBI

Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA and Elkon KB: Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Arthritis Rheum. 60:1775–1784. 2009. View Article : Google Scholar : PubMed/NCBI

Hughes GC and Choubey D: Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat Rev Rheumatol. 10:740–751. 2014. View Article : Google Scholar : PubMed/NCBI

Carreno PC, Sacedon R, Jimenez E, Vicente A and Zapata AG: Prolactin affects both survival and differentiation of T-cell progenitors. J Neuroimmunol. 160:135–145. 2005. View Article : Google Scholar : PubMed/NCBI

Legorreta-Haquet MV, Chavez-Rueda K, Chavez-Sanchez L, Cervera-Castillo H, Zenteno-Galindo E, Barile-Fabris L, Burgos-Vargas R, Álvarez-Hernández E and Blanco-Favela F: Function of treg cells decreased in patients with systemic lupus erythematosus due to the effect of prolactin. Medicine (Baltimore). 95:e23842016. View Article : Google Scholar : PubMed/NCBI

Dimitrov S, Lange T, Fehm HL and Born J: A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav Immun. 18:368–374. 2004. View Article : Google Scholar : PubMed/NCBI

Tsampalas M, Gridelet V, Berndt S, Foidart JM, Geenen V and Perrier d'Hauterive S: Human chorionic gonadotropin: A hormone with immunological and angiogenic properties. J Reprod Immunol. 85:93–98. 2010. View Article : Google Scholar : PubMed/NCBI

Lentz LS, Stutz AJ, Meyer N, Schubert K, Karkossa I, von Bergen M, Zenclussen AC and Schumacher A: Human chorionic gonadotropin promotes murine Treg cells and restricts pregnancy-harmful proinflammatory Th17 responses. Front Immunol. 13:9892472022. View Article : Google Scholar : PubMed/NCBI

Sha J, Liu F, Zhai J, Liu X, Zhang Q and Zhang B: Alteration of Th17 and Foxp3(+) regulatory T cells in patients with unexplained recurrent spontaneous abortion before and after the therapy of hCG combined with immunoglobulin. Exp Ther Med. 14:1114–1118. 2017. View Article : Google Scholar : PubMed/NCBI

Diao LH, Li GG, Zhu YC, Tu WW, Huang CY, Lian RC, Chen X, Li YY, Zhang T, Huang Y and Zeng Y: Human chorionic gonadotropin potentially affects pregnancy outcome in women with recurrent implantation failure by regulating the homing preference of regulatory T cells. Am J Reprod Immunol. 77:2017. View Article : Google Scholar : PubMed/NCBI

Schumacher A, Heinze K, Witte J, Poloski E, Linzke N, Woidacki K and Zenclussen AC: Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance. J Immunol. 190:2650–2658. 2013. View Article : Google Scholar : PubMed/NCBI

Iqbal J, Sun L, Kumar TR, Blair HC and Zaidi M: Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci USA. 103:14925–14930. 2006. View Article : Google Scholar : PubMed/NCBI

Qian H, Jia J, Yang Y, Bian Z and Ji Y: A follicle-stimulating hormone exacerbates the progression of periapical inflammation through modulating the cytokine release in periodontal tissue. Inflammation. 43:1572–1585. 2020. View Article : Google Scholar : PubMed/NCBI

Kvien TK, Uhlig T, Odegard S and Heiberg MS: Epidemiological aspects of rheumatoid arthritis: The sex ratio. Ann N Y Acad Sci. 1069:212–222. 2006. View Article : Google Scholar : PubMed/NCBI

Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Peets T, Baranauskaite A, et al: Women, men, and rheumatoid arthritis: Analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther. 11:R72009.PubMed/NCBI

Castagnetta LA, Carruba G, Granata OM, Stefano R, Miele M, Schmidt M, Cutolo M and Straub RH: Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol. 30:2597–2605. 2003.PubMed/NCBI

Nieminen P, Hamalainen W, Savinainen J, Lehtonen M, Lehtiniemi S, Rinta-Paavola J, Lehenkari P, Kääriäinen T, Joukainen A, Kröger H, et al: Metabolomics of synovial fluid and infrapatellar fat pad in patients with osteoarthritis or rheumatoid arthritis. Inflammation. 45:1101–1117. 2022. View Article : Google Scholar : PubMed/NCBI

Schmidt M, Weidler C, Naumann H, Anders S, Schölmerich J and Straub RH: Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes-androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. Arthritis Res Ther. 7:R938–R948. 2005. View Article : Google Scholar : PubMed/NCBI

Capellino S, Straub RH and Cutolo M: Aromatase and regulation of the estrogen-to-androgen ratio in synovial tissue inflammation: Common pathway in both sexes. Ann N Y Acad Sci. 1317:24–31. 2014. View Article : Google Scholar : PubMed/NCBI

Weitoft T, Larsson A and Ronnblom L: Serum levels of sex steroid hormones and matrix metalloproteinases after intra-articular glucocorticoid treatment in female patients with rheumatoid arthritis. Ann Rheum Dis. 67:422–424. 2008. View Article : Google Scholar : PubMed/NCBI

Capellino S, Montagna P, Villaggio B, Soldano S, Straub RH and Cutolo M: Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia. Clin Exp Rheumatol. 26:903–909. 2008.PubMed/NCBI

Schmidt M, Hartung R, Capellino S, Cutolo M, Pfeifer-Leeg A and Straub RH: Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis. Arthritis Rheum. 60:2913–2922. 2009. View Article : Google Scholar : PubMed/NCBI

Cenci S, Toraldo G, Weitzmann MN, Roggia C, Gao Y, Qian WP, Sierra O and Pacifici R: Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci USA. 100:10405–10410. 2003. View Article : Google Scholar : PubMed/NCBI

Garcia-Perez MA, Noguera I, Hermenegildo C, Martínez-Romero A, Tarín JJ and Cano A: Alterations in the phenotype and function of immune cells in ovariectomy-induced osteopenic mice. Hum Reprod. 21:880–887. 2006. View Article : Google Scholar : PubMed/NCBI

Yoneda T, Ishimaru N, Arakaki R, Kobayashi M, Izawa T, Moriyama K and Hayashi Y: Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. Endocrinology. 145:2384–2391. 2004. View Article : Google Scholar : PubMed/NCBI

Andersson A, Grahnemo L, Engdahl C, Stubelius A, Lagerquist MK, Carlsten H and Islander U: IL-17-producing үδT cells are regulated by estrogen during development of experimental arthritis. Clin Immunol. 161:324–332. 2015. View Article : Google Scholar : PubMed/NCBI

Zai Z, Xu Y, Qian X, Li Z, Ou Z, Zhang T, Wang L, Ling Y, Peng X, Zhang Y and Chen F: Estrogen antagonizes ASIC1a-induced chondrocyte mitochondrial stress in rheumatoid arthritis. J Transl Med. 20:5612022. View Article : Google Scholar : PubMed/NCBI

Ishizuka M, Hatori M, Suzuki T, Miki Y, Darnel AD, Tazawa C, Sawai T, Uzuki M, Tanaka Y, Kokubun S and Sasano H: Sex steroid receptors in rheumatoid arthritis. Clin Sci (Lond). 106:293–300. 2004. View Article : Google Scholar : PubMed/NCBI

Engdahl C, Borjesson AE, Forsman HF, Andersson A, Stubelius A, Krust A, Chambon P, Islander U, Ohlsson C, Carlsten H and Lagerquist MK: The role of total and cartilage-specific estrogen receptor alpha expression for the ameliorating effect of estrogen treatment on arthritis. Arthritis Res Ther. 16:R1502014. View Article : Google Scholar : PubMed/NCBI

Andersson A, Stubelius A, Karlsson MN, Engdahl C, Erlandsson M, Grahnemo L, Lagerquist MK and Islander U: Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis. Arthritis Res Ther. 17:322015. View Article : Google Scholar : PubMed/NCBI

Xu X, Yang H, Bullock WA, Gallant MA, Ohlsson C, Bellido TM and Main RP: Osteocyte estrogen receptor β (Ot-ERβ) regulates bone turnover and skeletal adaptive response to mechanical loading differently in male and female growing and adult mice. J Bone Miner Res. 38:186–197. 2023. View Article : Google Scholar : PubMed/NCBI

Sims NA, Dupont S, Krust A, Clement-Lacroix P, Minet D, Resche-Rigon M, Gaillard-Kelly M and Baron R: Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone. 30:18–25. 2002. View Article : Google Scholar : PubMed/NCBI

Bove R: Autoimmune diseases and reproductive aging. Clin Immunol. 149:251–264. 2015. View Article : Google Scholar

Cutolo M, Sulli A, Pizzorni C, Craviotto C and Straub RH: Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. Ann N Y Acad Sci. 992:107–117. 2003. View Article : Google Scholar : PubMed/NCBI

Yang DD, Krasnova A, Nead KT, Choueiri TK, Hu JC, Hoffman KE, Yu JB, Spratt DE, Feng FY, Trinh QD and Nguyen PL: Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer. Ann Oncol. 29:386–391. 2018. View Article : Google Scholar : PubMed/NCBI

Drevinskaite M, Dadoniene J, Miltiniene D, Patasius A and Smailyte G: Association between androgen deprivation therapy and the risk of inflammatory rheumatic diseases in men with prostate cancer: Nationwide Cohort Study in Lithuania. J Clin Med. 11:20392007. View Article : Google Scholar

Cutolo M, Seriolo B, Villaggio B, Pizzorni C, Craviotto C and Sulli A: Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci. 966:131–142. 2002. View Article : Google Scholar : PubMed/NCBI

Ganesan K, Selvam R, Abhirami R, Raju KV, Manohar BM and Puvanakrishnan R: Gender differences and protective effects of testosterone in collagen induced arthritis in rats. Rheumatol Int. 28:345–353. 2008. View Article : Google Scholar : PubMed/NCBI

Ganesan K, Balachandran C, Manohar BM and Puvanakrishnan R: Effects of testosterone, estrogen and progesterone on TNF-α mediated cellular damage in rat arthritic synovial fibroblasts. Rheumatol Int. 32:3181–3188. 2012. View Article : Google Scholar : PubMed/NCBI

Martin CS, Crastin A, Sagmeister MS, Turner JD, MacDonald L, Kurowska-Stolarska M, Scheel-Toellner D, Taylor AE, Gilligan LC, Storbeck K, et al: Inflammation dynamically regulates steroid hormone metabolism and action within macrophages in rheumatoid arthritis. J Autoimmun. 147:1032632024. View Article : Google Scholar : PubMed/NCBI

Weidler C, Struharova S, Schmidt M, Ugele B, Schölmerich J and Straub RH: Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: A prerequisite for local androgen deficiency. Arthritis Rheum. 52:1721–1729. 2005. View Article : Google Scholar : PubMed/NCBI

Straub RH, Harle P, Yamana S, Matsuda T, Takasugi K, Kishimoto T and Nishimoto N: Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study. Arthritis Rheum. 54:1778–1785. 2006. View Article : Google Scholar : PubMed/NCBI

Jurcovicova J, Svik K, Scsukova S, Bauerova K, Rovensky J and Stancikova M: Methotrexate treatment ameliorated testicular suppression and anorexia related leptin reduction in rats with adjuvant arthritis. Rheumatol Int. 29:1187–1191. 2009. View Article : Google Scholar : PubMed/NCBI

Stark K, Straub RH, Rovensky J, Blažičková S, Eiselt G and Schmidt M: CYB5A polymorphism increases androgens and reduces risk of rheumatoid arthritis in women. Arthritis Res Ther. 17:562015. View Article : Google Scholar : PubMed/NCBI

Park JS, Choi SY, Hwang SH, Kim SM, Choi J, Jung KA, Kwon JY, Kong YY, Cho ML and Park SH: CR6-interacting factor 1 controls autoimmune arthritis by regulation of signal transducer and activator of transcription 3 pathway and T helper type 17 cells. Immunology. 156:413–421. 2019. View Article : Google Scholar : PubMed/NCBI

Rontzsch A, Thoss K, Petrow PK, Henzgen S and Bräuer R: Amelioration of murine antigen-induced arthritis by dehydroepiandrosterone (DHEA). Inflamm Res. 53:189–198. 2004. View Article : Google Scholar : PubMed/NCBI

Sandoughi M, Kaykhaei MA, Langarizadeh E and Dashipour A: Effects of dehydroepiandrosterone on quality of life in premenopausal women with rheumatoid arthritis: A preliminary randomized clinical trial. Int J Rheum Dis. 23:1692–1697. 2020. View Article : Google Scholar : PubMed/NCBI

Hellberg S, Raffetseder J, Rundquist O, Magnusson R, Papapavlou G, Jenmalm MC, Ernerudh J and Gustafsson M: Progesterone dampens immune responses in in vitro activated CD4(+) T cells and affects genes associated with autoimmune diseases that improve during pregnancy. Front Immunol. 12:6721682021. View Article : Google Scholar : PubMed/NCBI

Khalkhali-Ellis Z, Seftor EA, Nieva DR, Handa RJ, Price RH Jr, Kirschmann DA, Baragi VM, Sharma RV, Bhalla RC, Moore TL and Hendrix MJ: Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthritis. J Rheumatol. 27:1622–1631. 2000.PubMed/NCBI

Jahanbakhshi M, Babaloo Z, Mortazavi-Jahromi SS, Shokri MM, Ahmadi H and Mirshafiey A: Modification of sexual hormones in rheumatoid arthritis patients by M2000 (β-D-mannuronic Acid) as a Novel NSAID with immunosuppressive property. Endocr Metab Immune Disord Drug Targets. 18:530–536. 2018. View Article : Google Scholar : PubMed/NCBI

Tengstrand B, Carlstrom K and Hafstrom I: Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism. Rheumatology (Oxford). 41:285–289. 2002. View Article : Google Scholar : PubMed/NCBI

Tengstrand B, Carlstrom K and Hafstrom I: Gonadal hormones in men with rheumatoid arthritis-from onset through 2 years. J Rheumatol. 36:887–892. 2009. View Article : Google Scholar : PubMed/NCBI

Cevik R, Em S, Gur A, Nas K, Sarac AJ and Colpan L: Sex and thyroid hormone status in women with rheumatoid arthritis: Are there any effects of menopausal state and disease activity on these hormones? Int J Clin Pract. 58:327–332. 2004. View Article : Google Scholar : PubMed/NCBI

Takeuchi T, Tanaka Y, Higashitani C, Iwai M, Komatsu K, Akazawa R and Lademacher C: A phase 2a, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral gonadotropin-releasing hormone antagonist, ASP1707, in postmenopausal female patients with rheumatoid arthritis taking methotrexate. Mod Rheumatol. 31:53–60. 2021. View Article : Google Scholar : PubMed/NCBI

Weitzmann MN and Pacifici R: Estrogen deficiency and bone loss: An inflammatory tale. J Clin Invest. 116:1186–1194. 2006. View Article : Google Scholar : PubMed/NCBI

Belenska-Todorova L, Zhivkova R, Markova M and Ivanovska N: Follicle stimulating hormone and estradiol alter immune response in osteoarthritic mice in an opposite manner. Int J Immunopathol Pharmacol. 35:205873842110161982021. View Article : Google Scholar : PubMed/NCBI

Zhang X, Qiao P, Guo Q, Liang Z, Pan J, Wu F, Wang X and Zhang L: High follicle-stimulating hormone level associated with risk of rheumatoid arthritis and disease activity. Front Endocrinol (Lausanne). 13:8628492022. View Article : Google Scholar : PubMed/NCBI

Vieira Borba V and Shoenfeld Y: Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding? Clin Rheumatol. 38:1263–1270. 2019. View Article : Google Scholar : PubMed/NCBI

Ram S, Blumberg D, Newton P, Anderson NR and Gama R: Raised serum prolactin in rheumatoid arthritis: genuine or laboratory artefact? Rheumatology (Oxford). 43:1272–1274. 2004. View Article : Google Scholar : PubMed/NCBI

Zoli A, Lizzio MM, Ferlisi EM, Massafra V, Mirone L, Barini A, Scuderi F, Bartolozzi F and Magaró M: ACTH, cortisol and prolactin in active rheumatoid arthritis. Clin Rheumatol. 21:289–293. 2002. View Article : Google Scholar : PubMed/NCBI

Han A, Kim JY, Kwak-Kim J and Lee SK: Menopause is an inflection point of age-related immune changes in women. J Reprod Immunol. 146:1033462021. View Article : Google Scholar : PubMed/NCBI

Humphreys JH, Verstappen SM, Hyrich KL, Chipping JR, Marshall T and Symmons DP: The incidence of rheumatoid arthritis in the UK: Comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register. Ann Rheum Dis. 72:1315–1320. 2013. View Article : Google Scholar : PubMed/NCBI

Mollard E, Pedro S, Chakravarty E, Clowse M, Schumacher R and Michaud K: The impact of menopause on functional status in women with rheumatoid arthritis. Rheumatology (Oxford). 57:798–802. 2018. View Article : Google Scholar : PubMed/NCBI

Beydoun HA, El-Amin R, McNeal M, Perry C and Archer DF: Reproductive history and postmenopausal rheumatoid arthritis among women 60 years or older: Third national health and nutrition examination survey. Menopause. 20:930–935. 2013. View Article : Google Scholar : PubMed/NCBI

Salliot C, Nguyen Y, Gusto G, Gelot A, Gambaretti J, Mariette X, Boutron-Ruault MC and Seror R: Female hormonal exposures and risk of rheumatoid arthritis in the French E3N-EPIC cohort study. Rheumatology (Oxford). 60:4790–4800. 2021. View Article : Google Scholar : PubMed/NCBI

Alpizar-Rodriguez D, Mueller RB, Moller B, Dudler J, Ciurea A, Zufferey P, Kyburz D, Walker UA, von Mühlenen I, Roux-Lombard P, et al: Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis. Rheumatology (Oxford). 56:1579–1585. 2017. View Article : Google Scholar : PubMed/NCBI

Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM and de Villiers TJ; STRAW + 10 Collaborative Group, : Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 97:1159–1168. 2012. View Article : Google Scholar : PubMed/NCBI

Engdahl C, Bondt A, Harre U, Raufer J, Pfeifle R, Camponeschi A, Wuhrer M, Seeling M, Mårtensson IL, Nimmerjahn F, et al: Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: A potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women. Arthritis Res Ther. 20:842018. View Article : Google Scholar : PubMed/NCBI

Guthrie KA, Dugowson CE, Voigt LF, Koepsell TD and Nelson JL: Does pregnancy provide vaccine-like protection against rheumatoid arthritis? Arthritis Rheum. 62:1842–1848. 2010. View Article : Google Scholar : PubMed/NCBI

Straub RH: The complex role of estrogens in inflammation. Endocr Rev. 28:521–574. 2007. View Article : Google Scholar : PubMed/NCBI

Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, et al: Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 374:1221–1231. 2016. View Article : Google Scholar : PubMed/NCBI

Orellana C, Wedren S, Kallberg H, Holmqvist M, Karlson EW, Alfredsson L and Bengtsson C; EIRA Study Group, : Parity and the risk of developing rheumatoid arthritis: Results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study. Ann Rheum Dis. 73:752–755. 2014. View Article : Google Scholar : PubMed/NCBI

Bondt A, Hafkenscheid L, Falck D, Kuijper TM, Rombouts Y, Hazes JMW, Wuhrer M and Dolhain RJEM: ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis. Ann Rheum Dis. 77:1130–1136. 2018.PubMed/NCBI

Forger F, Marcoli N, Gadola S, Möller B, Villiger PM and Østensen M: Pregnancy induces numerical and functional changes of CD4+CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis. 67:984–990. 2008. View Article : Google Scholar : PubMed/NCBI

Munoz-Suano A, Kallikourdis M, Sarris M and Betz AG: Regulatory T cells protect from autoimmune arthritis during pregnancy. J Autoimmun. 38:J103–J108. 2012. View Article : Google Scholar : PubMed/NCBI

Clowse ME, Chakravarty E, Costenbader KH, Chambers C and Michaud K: Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken). 64:668–674. 2012. View Article : Google Scholar : PubMed/NCBI

Littlejohn EA: Pregnancy and rheumatoid arthritis. Best Pract Res Clin Obstet Gynaecol. 64:52–58. 2020. View Article : Google Scholar : PubMed/NCBI

Lopez-Corbeto M, Martinez-Mateu S, Pluma A, Ferrer R, López-Lasanta M, De Agustín JJ, Barceló M, Julià A and Marsal S: The ovarian reserve as measured by the anti-Mullerian hormone is not diminished in patients with rheumatoid arthritis compared to the healthy population. Clin Exp Rheumatol. 39:337–343. 2021. View Article : Google Scholar : PubMed/NCBI

Brouwer J, Laven JS, Hazes JM, Schipper I and Dolhain RJ: Levels of serum anti-Mullerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res (Hoboken). 65:1534–1538. 2013. View Article : Google Scholar : PubMed/NCBI

Hampl JS and Papa DJ: Breastfeeding-related onset, flare, and relapse of rheumatoid arthritis. Nutr Rev. 59((8 Pt 1)): 264–268. 2001.PubMed/NCBI

Karlson EW, Mandl LA, Hankinson SE and Grodstein F: Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum. 50:3458–3467. 2004. View Article : Google Scholar : PubMed/NCBI

Adab P, Jiang C Q, Rankin E, Tsang YW, Lam TH, Barlow J, Thomas GN, Zhang WS and Cheng KK: Breastfeeding practice, oral contraceptive use and risk of rheumatoid arthritis among Chinese women: The guangzhou biobank cohort study. Rheumatology (Oxford). 53:860–866. 2014. View Article : Google Scholar : PubMed/NCBI

Chen H, Wang J, Zhou W, Yin H and Wang M: Breastfeeding and risk of rheumatoid arthritis: A systematic review and metaanalysis. J Rheumatol. 42:1563–1569. 2015. View Article : Google Scholar : PubMed/NCBI

Orellana C, Saevarsdottir S, Klareskog L, Karlson EW, Alfredsson L and Bengtsson C: Postmenopausal hormone therapy and the risk of rheumatoid arthritis: Results from the Swedish EIRA population-based case-control study. Eur J Epidemiol. 30:449–457. 2015. View Article : Google Scholar : PubMed/NCBI

Doran MF, Crowson CS, O'fallon WM and Gabriel SE: The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: A population based study. J Rheumatol. 31:207–213. 2004.PubMed/NCBI

Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, Pedersen BV, Wohlfahrt J and Frisch M: Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: A nationwide case-control study in Denmark. Arthritis Rheum. 56:1446–1453. 2007. View Article : Google Scholar : PubMed/NCBI

Qi S, Xin R, Guo W and Liu Y: Meta-analysis of oral contraceptives and rheumatoid arthritis risk in women. Ther Clin Risk Manag. 10:915–923. 2014.PubMed/NCBI

Walitt B, Pettinger M, Weinstein A, Katz J, Torner J, Wasko MC and Howard BV; Women's Health Initiative Investigators, : Effects of postmenopausal hormone therapy on rheumatoid arthritis: The women's health initiative randomized controlled trials. Arthritis Rheum. 59:302–310. 2008. View Article : Google Scholar : PubMed/NCBI

Yuk JS, Seo YS, Im YH and Kim JH: Menopausal hormone therapy and risk of seropositive rheumatoid arthritis: A nationwide cohort study in Korea. Semin Arthritis Rheum. 63:1522802023. View Article : Google Scholar : PubMed/NCBI

D'elia HF and Carlsten H: The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis. Scand J Immunol. 68:661–667. 2008. View Article : Google Scholar : PubMed/NCBI

Cutolo M, Balleari E, Giusti M, Intra E and Accardo S: Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum. 34:1–5. 1991. View Article : Google Scholar : PubMed/NCBI

Booji A, Biewenga-Booji CM, Huber-Bruning O, Cornelis C, Jacobs JW and Bijlsma JW: Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis. 55:811–815. 1996. View Article : Google Scholar : PubMed/NCBI

Hall GM, Larbre JP, Spector TD, Perry LA and Da Silva JA: A randomized trial of testosterone therapy in males with rheumatoid arthritis. Br J Rheumatol. 35:568–573. 1996. View Article : Google Scholar : PubMed/NCBI

Hall GM, Daniels M, Huskisson EC and Spector TD: A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis. 53:112–116. 1994. View Article : Google Scholar : PubMed/NCBI

Hall GM, Daniels M, Doyle DV and Spector TD: Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum. 37:1499–505. 1994. View Article : Google Scholar : PubMed/NCBI

Forsblad-D'elia H and Carlsten H: Hormone replacement therapy in postmenopausal women with rheumatoid arthritis stabilises bone mineral density by digital x-ray radiogrammetry in a randomised controlled trial. Ann Rheum Dis. 70:1167–1168. 2011. View Article : Google Scholar : PubMed/NCBI

Pullerits R, D'elia HF, Tarkowski A and Carlsten H: The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: A randomized controlled trial. Rheumatology (Oxford). 48:785–790. 2009. View Article : Google Scholar : PubMed/NCBI

Kass A, Hollan I, Fagerland MW, Gulseth HC, Torjesen PA and Førre ØT: Rapid anti-inflammatory effects of gonadotropin-releasing hormone antagonism in rheumatoid arthritis patients with high gonadotropin levels in the AGRA Trial. PLoS One. 10:e01394392015. View Article : Google Scholar : PubMed/NCBI

Kass AS, Forre OT, Fagerland MW, Gulseth HC, Torjesen PA and Hollan I: Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): A randomized, double-blind, placebo-controlled study. Scand J Rheumatol. 43:22–27. 2014. View Article : Google Scholar : PubMed/NCBI

Brown MA and Su MA: An inconvenient variable: Sex hormones and their impact on T cell responses. J Immunol. 202:1927–1933. 2019. View Article : Google Scholar : PubMed/NCBI